The trial did not resume
- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
Repairing this intricate, high-stress network is a formidable challenge
the program demonstrated a favorable safety profile but the Phase IIb obesity trial produced modest weight-loss effects (mean reduction in treated groups roughly 2.6 kg vs
For milder cases, you might see subtle boosts in energy, brain fog reduction, and mood lifts within the first week or two